Belhassen-García, M.; Sánchez-Puente, A.; Dorado-Díaz, P.-I.; López-Bernús, A.; Sampedro-Gómez, J.; Azibeiro-Melchor, R.; Marcano-Millán, E.; Rodríguez-Alonso, B.; Sánchez-Barrado, M.-E.; Hernández-García, I.;
et al. Date of Admission during COVID-19 Pandemic Impacted Patient Outcomes in Addition to the Higher Efficacy of Tocilizumab Plus High-Dose Corticosteroid Therapy Compared to Tocilizumab Alone. J. Clin. Med. 2022, 11, 198.
https://doi.org/10.3390/jcm11010198
AMA Style
Belhassen-García M, Sánchez-Puente A, Dorado-Díaz P-I, López-Bernús A, Sampedro-Gómez J, Azibeiro-Melchor R, Marcano-Millán E, Rodríguez-Alonso B, Sánchez-Barrado M-E, Hernández-García I,
et al. Date of Admission during COVID-19 Pandemic Impacted Patient Outcomes in Addition to the Higher Efficacy of Tocilizumab Plus High-Dose Corticosteroid Therapy Compared to Tocilizumab Alone. Journal of Clinical Medicine. 2022; 11(1):198.
https://doi.org/10.3390/jcm11010198
Chicago/Turabian Style
Belhassen-García, Moncef, Antonio Sánchez-Puente, Pedro-Ignacio Dorado-Díaz, Amparo López-Bernús, Jesús Sampedro-Gómez, Raúl Azibeiro-Melchor, Edgard Marcano-Millán, Beatriz Rodríguez-Alonso, María-Elisa Sánchez-Barrado, Ignacio Hernández-García,
and et al. 2022. "Date of Admission during COVID-19 Pandemic Impacted Patient Outcomes in Addition to the Higher Efficacy of Tocilizumab Plus High-Dose Corticosteroid Therapy Compared to Tocilizumab Alone" Journal of Clinical Medicine 11, no. 1: 198.
https://doi.org/10.3390/jcm11010198
APA Style
Belhassen-García, M., Sánchez-Puente, A., Dorado-Díaz, P.-I., López-Bernús, A., Sampedro-Gómez, J., Azibeiro-Melchor, R., Marcano-Millán, E., Rodríguez-Alonso, B., Sánchez-Barrado, M.-E., Hernández-García, I., Madruga, I., Hernández-Pérez, G., Carbonell, C., García-Aparicio, J., Burgos, L., López-Sánchez, E., Reina, C., Ramón, A.-M., Cestero-Ramírez, L.,
... Martín-Oterino, J.-Á.
(2022). Date of Admission during COVID-19 Pandemic Impacted Patient Outcomes in Addition to the Higher Efficacy of Tocilizumab Plus High-Dose Corticosteroid Therapy Compared to Tocilizumab Alone. Journal of Clinical Medicine, 11(1), 198.
https://doi.org/10.3390/jcm11010198
